Labcorp Holdings Inc. logo
Labcorp Holdings Inc. (LH)
Compare

Labcorp Holdings Inc. (LH) FCF Payout Ratio: 17.31%

Is Labcorp Holdings Inc.’s FCF payout ratio high or low?

Labcorp Holdings Inc.'s FCF payout ratio of 17.31% is 18% below its 3-year average of 21.11%, near the low end of its 3-year range (13.24%–29.06%).

17.85% below its 12-month average of 21.07%.

LH FCF Payout Ratio Chart

LH FCF Payout Ratio
19.96%-10.03% 1Y
Zoom

LH Average FCF Payout Ratio Chart

LH Current vs Average FCF Payout Ratio Chart

LH FCF Payout Ratio Metrics

FCF PAYOUT RATIO

17.31%

FCF PAYOUT RATIO AVG TTM

21.07%

FCF PAYOUT RATIO AVG 3Y

21.11%

FCF PAYOUT RATIO AVG 5Y

21.11%

FCF PAYOUT RATIO AVG 10Y

21.11%

FCF PAYOUT RATIO AVG 15Y

21.11%

FCF PAYOUT RATIO AVG 20Y

21.11%

CURRENT VS TTM AVG

-17.85%

CURRENT VS 3Y AVG

-18.00%

CURRENT VS 5Y AVG

-18.00%

CURRENT VS 10Y AVG

-18.00%

CURRENT VS 15Y AVG

-18.00%

CURRENT VS 20Y AVG

-18.00%

Payout Ratio Comparison

FCF Payout Ratio

17.3%

Earnings Payout Ratio

27.3%

Dividend Yield

1.08%

FCF Yield

6.27%

Annual FCF Payout Ratio History

YearFree Cash FlowDividends PaidFCF Payout Ratio
2025$1.21B$240.70M20.0%
2024$1.10B$243.10M22.2%
2023$874.10M$254.00M29.1%
2022$1.47B$195.20M13.2%
2021$2.65B$00.0%
2020$1.75B$00.0%
2019$1.04B$00.0%
2018$925.60M$00.0%
2017$1.14B$00.0%
2016$897.00M$00.0%
2015$726.60M$00.0%
2014$535.50M$00.0%
2013$616.50M$00.0%
2012$665.10M$00.0%
2011$709.90M$00.0%
2010$757.10M$00.0%
2009$747.70M$00.0%
2008$624.20M$00.0%
2007$566.40M$00.0%
2006$515.80M$00.0%
2005$480.60M$00.0%
2004$443.10M$00.0%
2003$480.70M$00.0%
2002$370.60M$00.0%
2001$227.90M$00.0%
2000$191.20M$9.50M5.0%
1999$111.10M$18.50M16.7%
1998$42.70M$18.50M43.3%
1997$109.90M$9.70M8.8%
1996($240.90M)$0N/A (Loss)

Formula: FCF Payout Ratio = Dividends Paid / Free Cash Flow × 100

FCF payout and earnings payout:

  • FCF represents operating cash flow after capital expenditures
  • FCF payout compares dividends paid with free cash flow
  • FCF payout above 100% means dividends paid exceeded free cash flow for the period
  • Earnings payout compares dividends paid with net income

Reading the series: Use the chart and table to compare dividend payments with cash generation over time.

Labcorp Holdings Inc. FCF Payout Ratio Formula & Definition

FCF Payout Ratio measures what percentage of free cash flow is paid out as dividends. Unlike earnings-based payout, it compares dividends with cash generated after capital expenditures.

Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute

Labcorp Holdings Inc. FCF Payout Ratio FAQ

What is the FCF payout ratio for Labcorp Holdings Inc. (LH)?
The FCF payout ratio for LH stock is 17.31%.
Is Labcorp Holdings Inc.'s FCF payout ratio high or low?
Labcorp Holdings Inc.'s FCF payout ratio of 17.31% is 18% below its 3-year average of 21.11%, near the low end of its 3-year range (13.24%–29.06%).
What is the TTM average FCF payout ratio for Labcorp Holdings Inc. (LH)?
The TTM average FCF payout ratio for LH stock is 21.07%.
What is the 3Y average FCF payout ratio for Labcorp Holdings Inc. (LH)?
The 3Y average FCF payout ratio for LH stock is 21.11%.
What is the 5Y average FCF payout ratio for Labcorp Holdings Inc. (LH)?
The 5Y average FCF payout ratio for LH stock is 21.11%.
What is the 10Y average FCF payout ratio for Labcorp Holdings Inc. (LH)?
The 10Y average FCF payout ratio for LH stock is 21.11%.
What is the 15Y average FCF payout ratio for Labcorp Holdings Inc. (LH)?
The 15Y average FCF payout ratio for LH stock is 21.11%.
What is the 20Y average FCF payout ratio for Labcorp Holdings Inc. (LH)?
The 20Y average FCF payout ratio for LH stock is 21.11%.

Labcorp Holdings Inc. FCF Payout Ratio History

DATEFCF PAYOUT RATIO
2025-12-3119.96%
2024-12-3122.18%
2023-12-3129.06%
2022-12-3113.24%
2000-12-314.97%
1999-12-3116.65%
1998-12-3143.33%
1997-12-318.83%

About Labcorp Holdings Inc.

Labcorp Holdings, Inc. offers vital diagnostic laboratory services, enabling medical professionals, healthcare facilities, pharmaceutical firms, scientific investigators, and patients to make well-informed and confident choices. The company commenced operations on April 16, 2024, and its main office is situated in Burlington, NC.

Burlington, NC
60,900 employees
Healthcare / Medical - Diagnostics & Research
Sector
Healthcare
Industry
Medical - Diagnostics & Research
CEO
Adam H. Schechter